HK2 and neoplasm: Furthermore, both 18F-FDG tumor accumulation and HK2 expression could respond the administration/withdrawal of FGFRi in NCI-H1581 xenografts correspondingly, which in turn suggested that the loss of 18F-FDG tumor uptake response to FGFRi treatment might be associated with the acquired FGFRi-resistance.